Please Wait.....
Report
Europe Hyaluronic Acid Market - Industry Trends and Forecast to 2030
Market Report I 2022-12-01 I 348 Pages I Data Bridge Market Research
The Europe hyaluronic acid market is projected to register a substantial CAGR of 8.1% from 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentation
Europe Hyaluronic Acid Market, By Grade (Cosmetic Grade and Pharmaceutical Grade), Type (Hydrolyzed Hyaluronic Acid, Sodium Acetylated Hyaluronic Acid, and Sodium Hyaluronate), Application (Aesthetics, Osteoarthritis, Pharmaceutical API, Cosmetics, Ophthalmology, and Others), End User (Medical Spas and Beauty Centers, Dermatology Clinics, and Cosmetic Surgery Centers), Distribution Channel (Direct Tender and Retail Sales), Country (Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, and Rest of Europe) Industry Trends and Forecast to 2030
Some of the major factors contributing to the growth of Europe hyaluronic acid market are:
- Increasing awareness towards anti-aging non-invasive surgeries and dermal fillers
- Growing development of hyaluronic acid-based products in the market
- Growing desire to improve one's appearance
Market Players
The major companies dealing in the Europe hyaluronic acid market are listed below:
- Fidia Farmaceutici S.p.A.
- AbbVie.
- Bloomage Biotechnology Co., Ltd.
- GALDERMA
- LG Chem
- Anika Therapeutics, Inc.
- Abbott
- Kewpie Corporation
- Merz Europe, Inc.
- LABORATOIRES FILLMED
- Prollenium Medical Technologies.
- Contipro a.s.
- Lifecore Biomedical, Inc.
- BioScience GmbH
- Teoxane
- Bioxis Pharmaceuticals
- Bohus BioTech AB
- RIVER PHARMA s.r.l.
- Symatese
- Stanford Chemicals owned by Oceania International LLC,
- Bioiberica S.A.U.
- GENESIS pharmacy services
- Brickell Men's Products
TABLE OF CONTENTS
1 INTRODUCTION 87
1.1 OBJECTIVES OF THE STUDY 87
1.2 MARKET DEFINITION 87
1.3 OVERVIEW OF THE EUROPE HYALURONIC ACID MARKET 87
1.4 CURRENCY AND PRICING 89
1.5 LIMITATIONS 89
1.6 MARKETS COVERED 89
2 EUROPE HYALURONIC ACID MARKET: SEGMENTATION 96
2.1 MARKETS COVERED 96
2.2 GEOGRAPHICAL SCOPE 97
2.3 YEARS CONSIDERED FOR THE STUDY 98
2.4 DBMR TRIPOD DATA VALIDATION MODEL 99
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 102
2.6 MULTIVARIATE MODELLING 103
2.7 GRADE SEGMENT LIFELINE CURVE 103
2.8 DBMR MARKET POSITION GRID 104
2.9 VENDOR SHARE ANALYSIS 106
2.10 MARKET END USER COVERAGE GRID 107
2.11 SECONDARY SOURCES 108
3 EXECUTIVE SUMMARY 109
4 PREMIUM INSIGHTS 112
4.1 PESTEL ANALYSIS 113
4.2 PORTER'S FIVE FORCES 114
4.3 NUMBER OF AESTHETIC SURGERY PROCEDURES 115
4.4 INDUSTRY INSIGHTS 116
5 REGULATORY FRAMEWORK 118
5.1 EGULATORY SCENARIO IN THE U.S. 118
5.2 REGULATORY SCENARIO IN EUROPE 119
5.3 REGULATORY SCENARIO IN CHINA 119
5.4 REGULATORY SCENARIO IN AUSTRALIA 120
6 MARKET OVERVIEW 121
6.1 DRIVERS 123
6.1.1 INCREASING AWARENESS TOWARDS COSMETIC INJECTABLES OR DERMAL FILLERS 123
6.1.2 USE OF INVASIVE HYALURONIC ACID BASED DERMAL FILLERS 123
6.1.3 RISE IN PRODUCT APPROVALS 124
6.1.4 GROWING POPULARITY OF NON-SURGICAL OR MINIMALLY INVASIVE COSMETIC PROCEDURES 124
6.2 RESTRAINTS 125
6.2.1 AVAILABILITY OF UNAUTHORIZED OR ALTERNATIVE DERMAL FILLERS TO HAMPER MARKET 125
6.2.2 POOR MEDICAL REIMBURSEMENT POLICIES 126
6.2.3 SIDE EFFECTS RELATED TO HYALURONIC ACID INJECTION 126
6.3 OPPORTUNITIES 127
6.3.1 NEW TECHNOLOGY AND DEVELOPMENTS IN HYALURONIC ACID PRODUCTS 127
6.3.2 NUTRICOSMETICS HYALURONIC ACID DERMAL FILLERS 127
6.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 128
6.3.4 INCREASING RESEARCH AND DEVELOPMENT 128
6.4 CHALLENGES 129
6.4.1 ESCALATING PRODUCT RECALL 129
6.4.2 LACK OF EXPERTISE 129
7 EUROPE HYALURONIC ACID MARKET, BY GRADE 130
7.1 OVERVIEW 131
7.2 COSMETIC GRADE 134
7.2.1 GENDER 134
7.2.1.1 FEMALE PRODUCTS 134
7.2.1.2 MEN'S PRODUCT 135
7.2.2 PRODUCT TYPE 135
7.2.2.1 SKIN CARE 135
7.2.2.2 MAKEUP 135
7.2.2.3 CLEANSING 135
7.2.2.4 HAIR CARE 135
7.2.2.5 OTHERS 135
7.2.3 PROCEDURE 136
7.2.3.1 WRINKLE REMOVAL 136
7.2.3.2 SKIN SMOOTHENING 136
7.2.3.3 FACE LIFT 136
7.2.3.4 LIP AUGMENTATION 136
7.2.3.5 CHIN AUGMENTATION 136
7.2.3.6 FAT INJECTION 137
7.2.3.7 FACE LINE CORRECTION 137
7.2.3.8 ACNE SCAR TREATMENT 137
7.2.3.9 LIP PLUM 137
7.2.3.10 EAR LOBE REJUVENATION 137
7.2.3.11 LIPOATROPHY TREATMENT 137
7.2.3.12 OTHERS 137
7.3 PHARMACEUTICAL GRADE 138
7.3.1 TYPE 138
7.3.1.1 MEDICAL GRADE HYALURONIC ACID 139
7.3.1.2 INJECTION GRADE HYALURONIC ACID 139
7.3.2 PRODUCT TYPE 139
7.3.2.1 TOPICAL PREPARATIONS 139
7.3.2.2 INTRA-ARTICULAR INJECTION 139
7.3.2.2.1 PREFILLED INJECTIONS 140
7.3.2.2.2 VIAL 140
7.3.2.3 EYE DROPS 140
7.3.2.4 ORAL PHARMACEUTICAL PREPARATIONS 140
7.3.2.5 OTHERS 140
8 EUROPE HYALURONIC ACID MARKET, BY TYPE 141
8.1 OVERVIEW 142
8.2 SODIUM HYALURONATE 145
8.2.1 MOLECULAR WEIGHT 146
8.2.1.1 HIGH MOLECULAR WEIGHT 146
8.2.1.2 LOW MOLECULAR WEIGHT 146
8.2.1.3 MEDIUM MOLECULAR WEIGHT 146
8.2.2 BY TYPE 146
8.2.2.1 COSMETIC GRADE 146
8.2.2.1.1 GENDER 147
8.2.2.1.1.1 FEMALE PRODUCTS 147
8.2.2.1.1.2 MEN'S PRODUCT 147
8.2.2.1.2 PRODUCT TYPE 147
8.2.2.1.2.1 SKIN CARE 147
8.2.2.1.2.2 MAKEUP 148
8.2.2.1.2.3 CLEANSING 148
8.2.2.1.2.4 HAIR CARE 148
8.2.2.1.2.5 OTHERS 148
8.2.2.2 PHARMACEUTICAL GRADE 148
8.2.2.2.1 TYPE 148
8.2.2.2.1.1 MEDICAL GRADE HYALURONIC ACID 148
8.2.2.2.1.2 INJECTION GRADE HYALURONIC ACID 148
8.2.2.2.2 PRODUCT TYPE 149
8.2.2.2.2.1 TOPICAL PREPARATIONS 149
8.2.2.2.2.2 INTRA-ARTICULAR INJECTION 149
8.2.2.2.2.2.1 PREFILLED INJECTIONS 149
8.2.2.2.2.2.2 VIAL 150
8.2.2.2.2.3 EYE DROPS 150
8.2.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS 150
8.2.2.2.2.5 OTHERS 150
8.3 HYDROLYZED HYALURONIC ACID 150
8.3.1 MOLECULAR WEIGHT 151
8.3.1.1 HIGH MOLECULAR WEIGHT 151
8.3.1.2 LOW MOLECULAR WEIGHT 151
8.3.1.3 MEDIUM MOLECULAR WEIGHT 151
8.3.2 BY TYPE 152
8.3.2.1 COSMETIC GRADE 152
8.3.2.1.1 GENDER 152
8.3.2.1.1.1 FEMALE PRODUCTS 152
8.3.2.1.1.2 MEN'S PRODUCT 152
8.3.2.1.2 PRODUCT TYPE 153
8.3.2.1.2.1 SKIN CARE 153
8.3.2.1.2.2 MAKEUP 153
8.3.2.1.2.3 CLEANSING 153
8.3.2.1.2.4 HAIR CARE 153
8.3.2.1.2.5 OTHERS 153
8.3.2.2 PHARMACEUTICAL GRADE 154
8.3.2.2.1 TYPE 154
8.3.2.2.1.1 MEDICAL GRADE HYALURONIC ACID 154
8.3.2.2.1.2 INJECTION GRADE HYALURONIC ACID 154
8.3.2.2.2 PRODUCT TYPE 155
8.3.2.2.2.1 TOPICAL PREPARATIONS 155
8.3.2.2.2.2 INTRA-ARTICULAR INJECTION 155
8.3.2.2.2.2.1 PREFILLED INJECTIONS 155
8.3.2.2.2.2.2 VIAL 156
8.3.2.2.2.3 EYE DROPS 156
8.3.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS 156
8.3.2.2.2.5 OTHERS 156
8.4 SODIUM ACETYLATED HYALURONIC ACID 157
8.4.1 MOLECULAR WEIGHT 158
8.4.1.1 HIGH MOLECULAR WEIGHT 158
8.4.1.2 LOW MOLECULAR WEIGHT 158
8.4.1.3 MEDIUM MOLECULAR WEIGHT 158
8.4.2 BY TYPE 158
8.4.2.1 COSMETIC GRADE 159
8.4.2.1.1 GENDER 159
8.4.2.1.1.1 FEMALE PRODUCTS 159
8.4.2.1.1.2 MEN'S PRODUCT 159
8.4.2.1.2 PRODUCT TYPE 159
8.4.2.1.2.1 SKIN CARE 160
8.4.2.1.2.2 MAKEUP 160
8.4.2.1.2.3 CLEANSING 160
8.4.2.1.2.4 HAIR CARE 160
8.4.2.1.2.5 OTHERS 160
8.4.2.2 PHARMACEUTICAL GRADE 160
8.4.2.2.1 TYPE 160
8.4.2.2.1.1 MEDICAL GRADE HYALURONIC ACID 161
8.4.2.2.1.2 INJECTION GRADE HYALURONIC ACID 161
8.4.2.2.2 PRODUCT TYPE 161
8.4.2.2.2.1 TOPICAL PREPARATIONS 161
8.4.2.2.2.2 INTRA-ARTICULAR INJECTION 161
8.4.2.2.2.2.1 PREFILLED INJECTIONS 162
8.4.2.2.2.2.2 VIAL 162
8.4.2.2.2.3 EYE DROPS 162
8.4.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS 162
8.4.2.2.2.5 OTHERS 162
9 EUROPE HYALURONIC ACID MARKET, BY APPLICATION 163
9.1 OVERVIEW 164
9.2 AESTHETICS 167
9.3 OSTEOARTHRITIS 167
9.4 COSMETICS 168
9.5 OPHTHALMOLOGY 169
9.6 PHARMACEUTICAL API 170
9.7 OTHERS 171
10 EUROPE HYALURONIC ACID MARKET, BY END USER 172
10.1 OVERVIEW 173
10.2 DERMATOLOGY CLINICS 176
10.3 COSMETIC SURGERY CENTERS 176
10.4 MEDICAL SPAS AND BEAUTY CENTERS 177
10.5 OTHERS 178
11 EUROPE HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL 179
11.1 OVERVIEW 180
11.2 RETAIL SALES 183
11.2.1 RETAIL PHARMACY 184
11.2.2 HOSPITAL PHARMACY 184
11.2.3 ONLINE PHARMACY 184
11.3 DIRECT TENDER 184
12 EUROPE HYALURONIC ACID MARKET, BY REGION 185
12.1 EUROPE 186
12.1.1 GERMANY 200
12.1.2 FRANCE 210
12.1.3 U.K. 220
12.1.4 ITALY 230
12.1.5 SPAIN 240
12.1.6 RUSSIA 250
12.1.7 TURKEY 260
12.1.8 BELGIUM 270
12.1.9 NETHERLANDS 281
12.1.10 SWITZERLAND 292
12.1.11 REST EUROPE 303
13 EUROPE HYALURONIC ACID MARKET: COMPANY LANDSCAPE 304
13.1 COMPANY SHARE ANALYSIS: EUROPE 304
14 SWOT ANALYSIS 305
15 COMPANY PROFILE 306
15.1 FIDIA FARMACEUTICI S.P.A. (2022) 306
15.1.1 COMPANY SNAPSHOT 306
15.1.2 REVENUE ANALYSIS 306
15.1.3 COMPANY SHARE ANALYSIS 307
15.1.4 PRODUCT PORTFOLIO 307
15.1.5 RECENT DEVELOPMENT 307
15.2 ABBVIE INC. 308
15.2.1 COMPANY SNAPSHOT 308
15.2.2 REVENUE ANALYSIS 308
15.2.3 COMPANY SHARE ANALYSIS 309
15.2.4 PRODUCT PORTFOLIO 309
15.2.5 RECENT DEVELOPMENTS 309
15.3 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED 310
15.3.1 COMPANY SNAPSHOT 310
15.3.2 COMPANY SHARE ANALYSIS 310
15.3.3 PRODUCT PORTFOLIO 311
15.3.4 RECENT DEVELOPMENTS 312
15.4 GALDERMA 313
15.4.1 COMPANY SNAPSHOT 313
15.4.2 COMPANY SHARE ANALYSIS 313
15.4.3 PRODUCT PORTFOLIO 314
15.4.4 RECENT DEVELOPMENTS 314
15.5 LG CHEM (2022) 315
15.5.1 COMPANY SNAPSHOT 315
15.5.2 REVENUE ANALYSIS 315
15.5.3 COMPANY SHARE ANALYSIS 316
15.5.4 PRODUCT PORTFOLIO 316
15.5.5 RECENT DEVELOPMENTS 316
15.6 ABBOTT (2022) 317
15.6.1 COMPANY SNAPSHOT 317
15.6.2 REVENUE ANALYSIS 317
15.6.3 PRODUCT PORTFOLIO 318
15.6.4 RECENT DEVELOPMENTS 318
15.7 ANIKA THERAPEUTICS, INC. 319
15.7.1 COMPANY SNAPSHOT 319
15.7.2 REVENUE ANALYSIS 319
15.7.3 COMPANY SHARE ANALYSIS 320
15.7.4 PRODUCT PORTFOLIO 320
15.7.5 RECENT DEVELOPMENTS 321
15.8 BIOSCIENCE GMBH 322
15.8.1 COMPANY SNAPSHOT 322
15.8.2 PRODUCT PORTFOLIO 322
15.8.3 RECENT DEVELOPMENT 322
15.9 BIOXIS PHARMACEUTICALS 323
15.9.1 COMPANY SNAPSHOT 323
15.9.2 PRODUCT PORTFOLIO 323
15.9.3 RECENT DEVELOPMENTS 323
15.10 BIOIBERICA S.A.U 324
15.10.1 COMPANY SNAPSHOT 324
15.10.2 PRODUCT PORTFOLIO 324
15.10.3 RECENT DEVELOPMENTS 325
15.11 BOHUS BIOTECH AB 326
15.11.1 COMPANY SNAPSHOT 326
15.11.2 PRODUCT PORTFOLIO 326
15.11.3 RECENT DEVELOPMENTS 326
15.12 BRICKELL MEN'S PRODUCTS 327
15.12.1 COMPANY SNAPSHOT 327
15.12.2 PRODUCT PORTFOLIO 327
15.12.3 RECENT DEVELOPMENT 327
15.13 CONTIPRO A.S. 328
15.13.1 COMPANY SNAPSHOT 328
15.13.2 PRODUCT PORTFOLIO 328
15.13.3 RECENT DEVELOPMENTS 328
15.14 FILLMED 329
15.14.1 COMPANY SNAPSHOT 329
15.14.2 PRODUCT PORTFOLIO 329
15.14.3 RECENT DEVELOPMENT 330
15.15 GENESIS 331
15.15.1 COMPANY SNAPSHOT 331
15.15.2 PRODUCT PORTFOLIO 331
15.15.3 RECENT DEVELOPMENT 331
15.16 HUONS 332
15.16.1 COMPANY SNAPSHOT 332
15.16.2 PRODUCT PORTFOLIO 332
15.16.3 RECENT DEVELOPMENTS 332
15.17 KEWPIE CORPORATION 333
15.17.1 COMPANY SNAPSHOT 333
15.17.2 PRODUCT PORTFOLIO 333
15.17.3 RECENT DEVELOPMENTS 333
15.18 LIFECORE BIOMEDICAL, INC.(2022) 334
15.18.1 COMPANY SNAPSHOT 334
15.18.2 REVENUE ANALYSIS 334
15.18.3 PRODUCT PORTFOLIO 335
15.18.4 RECENT DEVELOPMENTS 335
15.19 MERZ NORTH AMERICA, INC. (A SUBSIDIARY OF MERZ PHARMA) 336
15.19.1 COMPANY SNAPSHOT 336
15.19.2 PRODUCT PORTFOLIO 336
15.19.3 RECENT DEVELOPMENTS 336
15.20 PROLLENIUM MEDICAL TECHNOLOGIES 337
15.20.1 COMPANY SNAPSHOT 337
15.20.2 PRODUCT PORTFOLIO 337
15.20.3 RECENT DEVELOPMENTS 337
15.21 RIVER PHARMA S.R.L. 338
15.21.1 COMPANY SNAPSHOT 338
15.21.2 PRODUCT PORTFOLIO 338
15.21.3 RECENT DEVELOPMENT 338
15.22 SHANDONG TOPSCIENCE BIOTECH CO., LTD. 339
15.22.1 COMPANY SNAPSHOT 339
15.22.2 PRODUCT PORTFOLIO 339
15.22.3 RECENT DEVELOPMENTS 339
15.23 STANFORD CHEMICALS OWNED BY OCEANIA INTERNATIONAL LLC, 340
15.23.1 COMPANY SNAPSHOT 340
15.23.2 PRODUCT PORTFOLIO 340
15.23.3 RECENT DEVELOPMENTS 340
15.24 SYMATESE 341
15.24.1 COMPANY SNAPSHOT 341
15.24.2 PRODUCT PORTFOLIO 341
15.24.3 RECENT DEVELOPMENTS 341
15.25 TEOXANE 342
15.25.1 COMPANY SNAPSHOT 342
15.25.2 PRODUCT PORTFOLIO 342
15.25.3 RECENT DEVELOPMENTS 342
15.26 VIRCHOW BIOTECH 343
15.26.1 COMPANY SNAPSHOT 343
15.26.2 PRODUCT PORTFOLIO 343
15.26.3 RECENT DEVELOPMENTS 343
16 QUESTIONNAIRE 344
17 RELATED REPORTS 348
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security